Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1992 Sep;67(9):1082–1085. doi: 10.1136/adc.67.9.1082

Effect of taurine supplementation on fat and energy absorption in cystic fibrosis.

M De Curtis 1, F Santamaria 1, P Ercolini 1, L Vittoria 1, G De Ritis 1, V Garofalo 1, F Ciccimarra 1
PMCID: PMC1793622  PMID: 1417050

Abstract

In 10 children with cystic fibrosis and persisting steatorrhoea, supplementation with taurine (30-40 mg/kg/day) was given for two months as an adjunct to the usual pancreatic enzyme treatment. A three day fat and energy balance was performed in patients with cystic fibrosis, before and after the supplementation, and in seven healthy controls who did not receive taurine. Faecal fat was measured by a gravimetric method and stool energy was determined using a bomb calorimeter. Patients with cystic fibrosis, before and after taurine, and healthy controls received the same fat and energy intake (calculated by a dietitian). In patients with cystic fibrosis taurine did not produce any improvement of steatorrhoea (mean (SD) faecal fat 8.7 (3.3) v 11.2 (7.0) g/day, respectively before and after the supplementation), of faecal energy loss (0.978 (0.468) v 1.133 (0.539) MJ/day), of faecal fat expressed as percent of fat intake (13.4 (5.6) v 15.1 (9.8)%), and of faecal energy expressed as percent of energy intake (9.9 (3.6) v 11.2 (5.7)%). Healthy controls had significant lower fat (3.5 (2.3) g/day) and energy 0.576 (0.355) MJ/day faecal losses. In conclusion, taurine failed to decrease significantly fat and energy losses. Our study does not support the use of taurine supplementation in the nutritional management of cystic fibrosis.

Full text

PDF
1082

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belli D. C., Levy E., Darling P., Leroy C., Lepage G., Giguère R., Roy C. C. Taurine improves the absorption of a fat meal in patients with cystic fibrosis. Pediatrics. 1987 Oct;80(4):517–523. [PubMed] [Google Scholar]
  2. Colombo C., Arlati S., Curcio L., Maiavacca R., Garatti M., Ronchi M., Corbetta C., Giunta A. Effect of taurine supplementation on fat and bile acid absorption in patients with cystic fibrosis. Scand J Gastroenterol Suppl. 1988;143:151–156. doi: 10.3109/00365528809090237. [DOI] [PubMed] [Google Scholar]
  3. Darling P. B., Lepage G., Leroy C., Masson P., Roy C. C. Effect of taurine supplements on fat absorption in cystic fibrosis. Pediatr Res. 1985 Jun;19(6):578–582. doi: 10.1203/00006450-198506000-00015. [DOI] [PubMed] [Google Scholar]
  4. De Curtis M., Senterre J., Rigo J. Estimated and measured energy content of infant formulas. J Pediatr Gastroenterol Nutr. 1986 Sep-Oct;5(5):746–749. doi: 10.1097/00005176-198609000-00014. [DOI] [PubMed] [Google Scholar]
  5. Durie P. R., Bell L., Linton W., Corey M. L., Forstner G. G. Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut. 1980 Sep;21(9):778–786. doi: 10.1136/gut.21.9.778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fitzpatrick W. J., Zentler-Munro P. L., Northfield T. C. Ileal resection: effect of cimetidine and taurine on intrajejunal bile acid precipitation and lipid solubilisation. Gut. 1986 Jan;27(1):66–72. doi: 10.1136/gut.27.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fondacaro J. D., Heubi J. E., Kellogg F. W. Intestinal bile acid malabsorption in cystic fibrosis: a primary mucosal cell defect. Pediatr Res. 1982 Jun;16(6):494–498. doi: 10.1203/00006450-198206000-00019. [DOI] [PubMed] [Google Scholar]
  8. Galeano N. F., Darling P., Lepage G., Leroy C., Collet S., Giguère R., Roy C. C. Taurine supplementation of a premature formula improves fat absorption in preterm infants. Pediatr Res. 1987 Jul;22(1):67–71. doi: 10.1203/00006450-198707000-00016. [DOI] [PubMed] [Google Scholar]
  9. Järvenpä A. L. Feeding the low-birth-weight infant. IV. Fat absorption as a function of diet and duodenal bile acids. Pediatrics. 1983 Nov;72(5):684–689. [PubMed] [Google Scholar]
  10. Murphy J. L., Wootton S. A., Bond S. A., Jackson A. A. Energy content of stools in normal healthy controls and patients with cystic fibrosis. Arch Dis Child. 1991 Apr;66(4):495–500. doi: 10.1136/adc.66.4.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Okamoto E., Rassin D. K., Zucker C. L., Salen G. S., Heird W. C. Role of taurine in feeding the low-birth-weight infant. J Pediatr. 1984 Jun;104(6):936–940. doi: 10.1016/s0022-3476(84)80503-x. [DOI] [PubMed] [Google Scholar]
  12. Thompson G. N. Failure of taurine to improve fat absorption in cystic fibrosis. J Inherit Metab Dis. 1988;11 (Suppl 2):158–160. doi: 10.1007/BF01804224. [DOI] [PubMed] [Google Scholar]
  13. Thompson G. N., Robb T. A., Davidson G. P. Taurine supplementation, fat absorption, and growth in cystic fibrosis. J Pediatr. 1987 Oct;111(4):501–506. doi: 10.1016/s0022-3476(87)80108-7. [DOI] [PubMed] [Google Scholar]
  14. Weber A. M., Roy C. C., Morin C. L., Lasalle R. Malabsorption of bile acids in children with cystic fibrosis. N Engl J Med. 1973 Nov 8;289(19):1001–1005. doi: 10.1056/NEJM197311082891903. [DOI] [PubMed] [Google Scholar]
  15. Zentler-Munro P. L., Fitzpatrick W. J., Batten J. C., Northfield T. C. Effect of intrajejunal acidity on aqueous phase bile acid and lipid concentrations in pancreatic steatorrhoea due to cystic fibrosis. Gut. 1984 May;25(5):500–507. doi: 10.1136/gut.25.5.500. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES